Encycle Therapeutics

A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Toronto, CA
10 (est)
Encycle Therapeutics was founded in 2012 and is headquartered in Toronto, CA

Encycle Therapeutics Locations

Toronto, CA

Encycle Therapeutics Metrics

Encycle Therapeutics Summary

Founding Date


Total Funding

$4.63 M

Latest funding size

$2.13 M

Time since last funding

about 1 year


Encycle Therapeutics's latest funding round of $2.13 M was in September 2015. In total, Encycle Therapeutics has raised $4.63 M.
17% of current employees of Encycle Therapeutics are female and 83% are male.

Encycle Therapeutics News

Encycle Therapeutics Company Life

You may also be interested in